Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001193125-26-467330

Director sold 1,381,762 shares at an average $38.75 ($53,536,738)

  • Director disposed of 3,036,758 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Gold Daniel Allen · Director

Table I: Non-derivative

10 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-16 Sale : show line 1 in the form −79,461 $39.17 $3,112,487 13,609,705 I
2026-11-16 Sale : show line 2 in the form −550,280 $39.17 $21,554,468 1,042,200 I
2026-11-16 Sale : show line 3 in the form −18,927 $38.99 $737,964 13,590,778 I
2026-11-16 Sale : show line 4 in the form −131,073 $38.99 $5,110,536 911,127 I
2026-11-17 Other disposition : show line 5 in the form −2,635,169 5,806,259 I
2026-11-17 Other disposition : show line 6 in the form −15,969 13,574,809 I
2026-11-17 Other disposition : show line 7 in the form −385,620 525,507 I
2026-11-17 Sale : show line 8 in the form −75,716 $38.24 $2,895,380 13,499,093 I
2026-11-17 Sale : show line 9 in the form −525,507 $38.24 $20,095,388 0 I
2026-11-17 Sale : show line 10 in the form −798 $38.24 $30,516 5,805,461 I
Open-market sales · 1,381,762 sh · avg $38.75 · $53,536,738
Loading xslF345X06/ownership.xml…